Overcoming clinical challenges in the management of invasive fungal infections in low- and middle-income countries (LMIC)

References

• Kaur H, Chakrabarti A. Strategies to reduce mortality in adult and neonatal candidemia in developing countries. J Fungi (Basel). 2017 Jul 19;3(3):41. doi: 10.3390/jof3030041
   PubMedGoogle Scholar
• Rudramurthy SM, Singh G, Hallur V, et al. High fungal spore burden with predominance of Aspergillus in hospital air of a tertiary care hospital in Chandigarh. Indian J Med Microbiol. 2016 Oct;34(4):529–532. doi: 10.4103/0255-0857.195359
   PubMed Web of Science ®Google Scholar
• Chakrabarti A. Introduction. In: Chakrabarti A, editor. Clinical practice of medical mycology in Asia. Singapore: Springer Singapore; 2020. p. 1–6. doi: 10.1007/978-981-13-9459-1_1
   Google Scholar
• The World Bank in Middle Income Countries. 2022 [cited 2023 Aug 7]. Available from: https://www.worldbank.org/en/country/mic/overview#:~:text=Middle%20income%20countries%20are%20home,62%25%20of%20the%20world%27s%20poor
   Google Scholar
• Bongomin F, Adetona Fayemiwo S. Epidemiology of fungal diseases in Africa: a review of diagnostic drivers. Curr Med Mycol. 2021 Mar;7(1):63–70. doi: 10.18502/cmm.7.1.6246
   PubMedGoogle Scholar
• Sifuentes-Osornio J, Corzo-Leon DE, Ponce-de-Leon LA. Epidemiology of invasive fungal infections in Latin America. Curr Fungal Infect Rep. 2012 Mar;6(1):23–34. doi: 10.1007/s12281-011-0081-7
   PubMedGoogle Scholar
• Colombo AL, Nucci M, Park BJ, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006 Aug;44(8):2816–2823. doi: 10.1128/JCM.00773-06
   PubMed Web of Science ®Google Scholar
• Global Fungal Infection Forum 4 in Lima. [cited 2023 May 26]. Available from: https://www.gaffi.org/global-fungal-infection-forum-4-in-lima/
   Google Scholar
• Ray A, Aayilliath KA, Banerjee S, et al. Burden of serious fungal infections in India. Open Forum Infect Dis. 2022 Dec;9(12):ofac603. doi: 10.1093/ofid/ofac603
   PubMed Web of Science ®Google Scholar
• Zhou LH, Jiang YK, Li RY, et al. Risk-based Estimate of human fungal disease burden, China. Emerg Infect Dis. 2020 Sep;26(9):2137–2147. doi: 10.3201/eid2609.200016
   PubMed Web of Science ®Google Scholar
• Wahyuningsih R, Adawiyah R, Sjam R, et al. Serious fungal disease incidence and prevalence in Indonesia. Mycoses. 2021 Oct;64(10):1203–1212. doi: 10.1111/myc.13304
   PubMed Web of Science ®Google Scholar
• Rayens E, Norris KA. Prevalence and healthcare burden of fungal infections in the United States, 2018. Open Forum Infect Dis. 2022 Jan;9(1):ofab593. doi: 10.1093/ofid/ofab593
   PubMed Web of Science ®Google Scholar
• Bongomin F, Gago S, Oladele RO, et al. Global and multi-national prevalence of fungal diseases—estimate precision. J Fungi (Basel). 2017 Oct 18;3(4):57. doi: 10.3390/jof3040057
   PubMedGoogle Scholar
• Chakrabarti A, Sood P, Rudramurthy SM, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive care Med. 2015 Feb;41(2):285–295. doi: 10.1007/s00134-014-3603-2
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Sood P, Rudramurthy SM, et al. Characteristics, outcome and risk factors for mortality of paediatric patients with ICU-acquired candidemia in India: a multicentre prospective study. Mycoses. 2020 Jul 17;63(11):1149–1163. doi: 10.1111/myc.13145
   Web of Science ®Google Scholar
• Cook A, Ferreras-Antolin L, Adhisivam B, et al. Neonatal invasive candidiasis in low- and middle-income countries: data from the NeoOBS study. Med Mycol. 2023 Mar 2;61(3). doi: 10.1093/mmy/myad010
   PubMed Web of Science ®Google Scholar
• Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019 Jul;25(7):792–798. doi: 10.1016/j.cmi.2019.03.028
   PubMed Web of Science ®Google Scholar
• Yamin D, Akanmu MH, Al Mutair A, et al. Global prevalence of Antifungal-Resistant Candida parapsilosis: a systematic review and meta-analysis. Trop Med Infect Dis. 2022 Aug 16;7(8):188. doi: 10.3390/tropicalmed7080188
   PubMedGoogle Scholar
• Chakrabarti A, Rudramurthy SM, Kale P, et al. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre. Clin Microbiol Infect. 2014 Feb;20(2):O83–9. doi: 10.1111/1469-0691.12337
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Singh K, Narang A, et al. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India. J Clin Microbiol. 2001 May;39(5):1702–1706. doi: 10.1128/JCM.39.5.1702-1706.2001
   PubMed Web of Science ®Google Scholar
• Shastri PS, Shankarnarayan SA, Oberoi J, et al. Candida auris candidaemia in an intensive care unit - prospective observational study to evaluate epidemiology, risk factors, and outcome. J Crit Care. 2020 Jun;57:42–48.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Sood P. On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points. J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001318
   Web of Science ®Google Scholar
• Bongomin F, Asio LG, Baluku JB, et al. Chronic pulmonary aspergillosis: notes for a clinician in a resource-limited setting where there is no mycologist. J Fungi (Basel). 2020 Jun 2;6(2):75. doi: 10.3390/jof6020075
   PubMedGoogle Scholar
• Korula A, Abraham A, Abubacker FN, et al. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-experience from a developing country. Mycoses. 2017 Oct;60(10):686–691. doi: 10.1111/myc.12646
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Kaur H, Savio J, et al. Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study). J Crit Care. 2019 Jun;51:64–70.
   PubMed Web of Science ®Google Scholar
• Rudramurthy SM, Paul RA, Chakrabarti A, et al. Invasive aspergillosis by Aspergillus flavus: epidemiology, diagnosis, antifungal resistance, and management. J Fungi (Basel). 2019 Jul 1;5(3):55. doi: 10.3390/jof5030055
   PubMedGoogle Scholar
• Chakrabarti A, Rudramurthy SM, Panda N, et al. Epidemiology of chronic fungal rhinosinusitis in rural India. Mycoses. 2015 May;58(5):294–302. doi: 10.1111/myc.12314
   PubMed Web of Science ®Google Scholar
• Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel). 2019 Mar 21;5(1):26. doi: 10.3390/jof5010026
   PubMedGoogle Scholar
• Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021 Mar 4;9(3):523. doi: 10.3390/microorganisms9030523
   PubMed Web of Science ®Google Scholar
• Marak RS, Misra R, Ansari MS, et al. Successful medical management of renal zygomycosis: a summary of two cases and a review of the Indian literature. Med Mycol. 2010 Dec;48(8):1088–1095. doi: 10.3109/13693781003753477
   PubMed Web of Science ®Google Scholar
• Wei LW, Zhu PQ, Chen XQ, et al. Mucormycosis in Mainland China: a systematic review of case reports. Mycopathologia. 2022 Feb;187(1):1–14. doi: 10.1007/s11046-021-00607-4
   PubMed Web of Science ®Google Scholar
• Muthu V, Agarwal R, Rudramurthy SM, et al. Multicenter case-control study of COVID-19-Associated mucormycosis outbreak, India. Emerg Infect Dis. 2023 Jan;29(1):8–19. doi: 10.3201/eid2901.220926
   PubMed Web of Science ®Google Scholar
• Muthu V, Rudramurthy SM, Chakrabarti A, et al. Epidemiology and pathophysiology of COVID-19-Associated Mucormycosis: India versus the rest of the world. Mycopathologia. 2021 Dec;186(6):739–754. doi: 10.1007/s11046-021-00584-8
   PubMed Web of Science ®Google Scholar
• Patel A, Agarwal R, Rudramurthy SM, et al. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis. 2021 Sep;27(9):2349–2359. doi: 10.3201/eid2709.210934
   PubMed Web of Science ®Google Scholar
• Patel AK, Bakshi H, Shah K, et al. Risk factors for COVID-19 associated mucormycosis in India: a case control study. Med Mycol. 2022;60(7):myac044. doi: 10.1093/mmy/myac044
   PubMed Web of Science ®Google Scholar
• Cole DC, Govender NP, Chakrabarti A, et al. Improvement of fungal disease identification and management: combined health systems and public health approaches. Lancet Infect Dis. 2017 Dec;17(12):e412–e419. doi: 10.1016/S1473-3099(17)30308-0
   PubMed Web of Science ®Google Scholar
• Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017 Aug;17(8):873–881. doi: 10.1016/S1473-3099(17)30243-8
   PubMed Web of Science ®Google Scholar
• Denning DW. Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized.Philos Trans R Soc Lond B Biol Sci. 1709 [2016 Dec 5];371(1709):20150468. doi: 10.1098/rstb.2015.0468
   Google Scholar
• Falci DR, Monteiro AA, Braz Caurio CF, et al. Histoplasmosis, an underdiagnosed disease affecting people living with HIV/AIDS in Brazil: results of a Multicenter prospective cohort study using both classical mycology tests and Histoplasma urine antigen detection. Open Forum Infect Dis. 2019;6(4): doi: 10.1093/ofid/ofz073
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Kaur H, Rudramurthy SM, et al. Brain abscess due to cladophialophora bantiana: a review of 124 cases. Med Mycol. 2016 Feb;54(2):111–119. doi: 10.1093/mmy/myv091
   PubMed Web of Science ®Google Scholar
• Chitasombat MN, Jongkhajornpong P, Lekhanont K, et al. Recent update in diagnosis and treatment of human pythiosis. PeerJ. 2020;8:e8555. doi: 10.7717/peerj.8555
   PubMed Web of Science ®Google Scholar
• Hahn RC, Hagen F, Mendes RP, et al. Paracoccidioidomycosis: Current status and future trends. Clin Microbiol Rev. 2022 Dec 21;35(4):e0023321. doi: 10.1128/cmr.00233-21
   PubMed Web of Science ®Google Scholar
• Yan G, Chew KL, Chai LYA. Update on non-culture-based diagnostics for invasive fungal disease. Mycopathologia. 2021 Oct;186(5):575–582. doi: 10.1007/s11046-021-00549-x
   PubMed Web of Science ®Google Scholar
• Schelenz S, Owens K, Guy R, et al. National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: evidence of sub-optimal practice. J Infect. 2019 Aug;79(2):167–173. doi: 10.1016/j.jinf.2019.06.009
   PubMed Web of Science ®Google Scholar
• Chindamporn A, Chakrabarti A, Li R, et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia fungal working group (AFWG) initiative. Med Mycol. 2018 Jun 1;56(4):416–425. doi: 10.1093/mmy/myx066
   PubMed Web of Science ®Google Scholar
• Falci DR, Pasqualotto AC. Clinical mycology in Latin America and the Caribbean: a snapshot of diagnostic and therapeutic capabilities. Mycoses. 2019 Apr;62(4):368–373. doi: 10.1111/myc.12890
   PubMed Web of Science ®Google Scholar
• Driemeyer C, Falci DR, Oladele RO, et al. The current state of clinical mycology in Africa: a European Confederation of medical mycology and international Society for human and Animal mycology survey. Lancet Microbe. 2022 Jun;3(6):e464–e470. doi: 10.1016/S2666-5247(21)00190-7
   PubMedGoogle Scholar
• Chen M, Al-Hatmi AM, Chen Y, et al. Cryptococcosis and tuberculosis co-infection in mainland China. Emerg Microbes Infect. 2016 Sep 7;5(9):e98. doi: 10.1038/emi.2016.95
   PubMedGoogle Scholar
• Ekeng BE, Oladele RO, Emanghe UE, et al. Prevalence of histoplasmosis and molecular characterization of Histoplasma species in patients with presumptive pulmonary tuberculosis in Calabar, Nigeria. Open Forum Infect Dis. 2022 Aug;9(8):ofac368. doi: 10.1093/ofid/ofac368
   PubMed Web of Science ®Google Scholar
• Kuate MPN, Ekeng BE, Kwizera R, et al. Histoplasmosis overlapping with HIV and tuberculosis in sub-Saharan Africa: challenges and research priorities. Ther Adv Infect Dis. 2021 Jan;8:20499361211008675.
   Web of Science ®Google Scholar
• Mohamed A, Obanda BA, Njeri HK, et al. Serological evidence of chronic pulmonary aspergillosis in tuberculosis patients in Kenya. BMC Infect Dis. 2022 Oct 25;22(1):798. doi: 10.1186/s12879-022-07782-9
   PubMed Web of Science ®Google Scholar
• Page ID, Byanyima R, Hosmane S, et al. Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation. Eur Respir J. 2019 Mar;53(3):1801184. doi: 10.1183/13993003.01184-2018
   PubMed Web of Science ®Google Scholar
• Rajeshwari B, Shanmugam S, Niamath S, et al. Vertebral cryptococcosis infection in an immunocompetent host: a rare case report. J Clin Diagn Res. 2019 May 29;13(1):ED17–ED19.
   Web of Science ®Google Scholar
• Huang CT, Tsai YJ, Fan JY, et al. Cryptococcosis and tuberculosis co-infection at a university hospital in Taiwan, 1993-2006. Infection. 2010 Oct;38(5):373–379. doi: 10.1007/s15010-010-0045-9
   PubMed Web of Science ®Google Scholar
• Rutakingirwa MK, Cresswell FV, Kwizera R, et al. Tuberculosis in HIV-Associated cryptococcal meningitis is associated with an increased risk of death. J Clin Med. 2020 Mar 13;9(3):781. doi: 10.3390/jcm9030781
   PubMed Web of Science ®Google Scholar
• Suresh CS, Ninan MM, Zachariah A, et al. Cryptococcosis with tuberculosis: overlooked coinfections. J Glob Infect Dis. 2021 Jul;13(3):139–141. doi: 10.4103/jgid.jgid_330_20
   PubMed Web of Science ®Google Scholar
• Souza SL, Feitoza PV, Araújo JR, et al. Causes of death among patients with acquired immunodeficiency syndrome autopsied at the Tropical Medicine Foundation of Amazonas. Rev Soc Bras Med Trop. 2008 May;41(3):247–251. doi: 10.1590/S0037-86822008000300005
   PubMed Web of Science ®Google Scholar
• Lowes D, Al-Shair K, Newton PJ, et al. Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir J. 2017 Feb;49(2):1601062. doi: 10.1183/13993003.01062-2016
   PubMed Web of Science ®Google Scholar
• Kwizera R, Katende A, Bongomin F, et al. Misdiagnosis of chronic pulmonary aspergillosis as pulmonary tuberculosis at a tertiary care center in Uganda: a case series. J Med Case Rep. 2021 Mar 30;15(1):140. doi: 10.1186/s13256-021-02721-9
   PubMedGoogle Scholar
• Laursen CB, Davidsen JR, Van Acker L, et al. Cpanet registry—an international chronic pulmonary aspergillosis registry. J Fungi (Basel). 2020 Jun 29;6(3):96. doi: 10.3390/jof6030096
   PubMedGoogle Scholar
• Pickering JW, Sant HW, Bowles CA, et al. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2005 Dec;43(12):5957–5962. doi: 10.1128/JCM.43.12.5957-5962.2005
   PubMed Web of Science ®Google Scholar
• Bloos F, Held J, Kluge S, et al. (1 –> 3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial. Intensive care Med. 2022 Jul;48(7):865–875. doi: 10.1007/s00134-022-06733-x
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1–50. doi: 10.1093/cid/civ933
   PubMedGoogle Scholar
• Logan C, Martin-Loeches I, Bicanic T. Invasive candidiasis in critical care: challenges and future directions. Intensive care Med. 2020 Nov;46(11):2001–2014. doi: 10.1007/s00134-020-06240-x
   PubMed Web of Science ®Google Scholar
• Tan BH, Chakrabarti A, Patel A, et al. Clinicians’ challenges in managing patients with invasive fungal diseases in seven Asian countries: an Asia fungal working group (AFWG) survey. Int J Infect Dis. 2020 Jun;95:471–480.
   PubMed Web of Science ®Google Scholar
• Soman R, Sunavala A. Challenges, pitfalls, and possible solution for Asian countries. In: Chakrabarti A, editor. Clinical practice of medical mycology in Asia. Singapore: Springer Singapore; 2020. p. 317–323. doi: 10.1007/978-981-13-9459-1_21
   Google Scholar
• Beardsley J, Sorrell TC, Chen S-A. Central nervous system cryptococcal infections in non-HIV infected patients. Journal Of Fungi. 2019;5(3):71. doi: 10.3390/jof5030071
   Web of Science ®Google Scholar
• Patel A, Kaur H, Xess I, et al. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020 Jul;26(7):.e944.9–.e944.15. doi: 10.1016/j.cmi.2019.11.021
   Web of Science ®Google Scholar
• Pamidimukkala U, Sudhaharan S, Kancharla A, et al. Mucormycosis due to apophysomyces species complex- 25 years’ experience at a tertiary care hospital in southern India. Med Mycol. 2020 Jun 1;58(4):425–433. doi: 10.1093/mmy/myz081
   PubMed Web of Science ®Google Scholar
• Lamaris GA, Ben-Ami R, Lewis RE, et al. Increased virulence of zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of Zygomycosis. J Infect Dis. 2009;199(9):1399–1406. doi: 10.1086/597615
   PubMed Web of Science ®Google Scholar
• Soman R, Gupta N, Shetty A, et al. Deferasirox in mucormycosis: hopefully, not defeated. J Antimicrob Chemother. 2012 Mar;67(3):783–784. doi: 10.1093/jac/dkr529
   PubMed Web of Science ®Google Scholar
• Patel A, Patel K, Patel K, et al. Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID-19-associated mucormycosis in a real-life setting. Mycoses. 2022 Mar;65(3):312–316. doi: 10.1111/myc.13420
   PubMed Web of Science ®Google Scholar
• Soman R, Chakraborty S, Joe G. Posaconazole or isavuconazole as sole or predominant antifungal therapy for COVID-19-associated mucormycosis. A retrospective observational case series. Int J Infect Dis. 2022 Jul;120:177–178. doi: 10.1016/j.ijid.2022.04.009
   PubMed Web of Science ®Google Scholar
• Seidel D, Duran Graeff LA, Vehreschild M, et al. FungiScope() -Global emerging fungal infection registry. Mycoses. 2017 Aug;60(8):508–516. doi: 10.1111/myc.12631
   PubMed Web of Science ®Google Scholar
• Nair R, Dutta PK, Talwar A. An overview of National AIDS Control Program (NACP) with special reference to targeted intervention: issues & challenges. J Commun Dis. 2010 Jun;42(2):81–90.
   PubMedGoogle Scholar
• Baluku JB, Nuwagira E, Bongomin F, et al. Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities. Int J Tuberc Lung Dis. 2021 Jul 1;25(7):537–546. doi: 10.5588/ijtld.21.0034
   PubMed Web of Science ®Google Scholar
• Verma R, Khanna P, Mehta B. Revised national tuberculosis control program in India: the need to strengthen. Int J Prev Med. 2013 Jan;4(1):1–5.
   PubMedGoogle Scholar
• Garcia PJ, You P, Fridley G, et al. Point-of-care diagnostic tests for low-resource settings. Lancet Glob Health. 2015 May;3(5):e257–8. doi: 10.1016/S2214-109X(15)70089-6
   PubMed Web of Science ®Google Scholar
• Denning DW, Page ID, Chakaya J, et al. Case definition of chronic pulmonary aspergillosis in resource-constrained settings. Emerg Infect Dis. 2018 Aug;24(8). doi: 10.3201/eid2408.171312
   PubMed Web of Science ®Google Scholar
• Dou YH, Du JK, Liu HL, et al. The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis. Diagn Microbiol Infect Dis. 2013 Aug;76(4):464–469. doi: 10.1016/j.diagmicrobio.2013.04.023
   PubMed Web of Science ®Google Scholar
• Barnes R, Earnshaw S, Herbrecht R, et al. Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients. Clin Ther. 2015 Jun 1;37(6):1317–1328.e2. doi: 10.1016/j.clinthera.2015.03.021
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Mohamed N, Capparella MR, et al. The role of diagnostics-driven antifungal stewardship in the management of invasive fungal infections: a systematic literature review. Open Forum Infect Dis. 2022;9(7): doi: 10.1093/ofid/ofac234
   Web of Science ®Google Scholar
• Jarvis JN, Lawrence DS, Meya DB, et al. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis. N Engl J Med. 2022 Mar 24;386(12):1109–1120. doi: 10.1056/NEJMoa2111904
   PubMed Web of Science ®Google Scholar
• Reboli AC, Rotstein C, Kett DH, et al. Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients. PharmacoEconomics. 2011 Aug;29(8):705–717. doi: 10.2165/11584810-000000000-00000
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Anil Kumar V, Sharma C, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):919–926. doi: 10.1007/s10096-013-2027-1
   PubMed Web of Science ®Google Scholar
• Gupta P, Malhotra HS, Saxena P, et al. Utility of itraconazole and terbinafine in mucormycosis: a proof-of-concept analysis. J Investig Med. 2022 Apr;70(4):914–918. doi: 10.1136/jim-2021-002179
   PubMed Web of Science ®Google Scholar
• Van Cutsem J, Van Gerven F, Fransen J, et al. Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B. Chemotherapy. 1989;35(4):267–272. doi: 10.1159/000238681
   PubMed Web of Science ®Google Scholar
• Mosquera J, Warn PA, Rodriguez-Tudela JL, et al. Treatment of absidia corymbifera infection in mice with amphotericin B and itraconazole. J Antimicrob Chemother. 2001 Oct;48(4):583–586. doi: 10.1093/jac/48.4.583
   PubMed Web of Science ®Google Scholar
• Pastor FJ, Ruiz-Cendoya M, Pujol I, et al. In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella. Antimicrob Agents Chemother. 2010 Nov;54(11):4550–4555. doi: 10.1128/AAC.00786-10
   PubMed Web of Science ®Google Scholar
• Lass-Florl C, Alastruey-Izquierdo A, Gupta R, et al. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases. Indian J Med Microbiol. 2022 Oct;40(4):480–484. doi: 10.1016/j.ijmmb.2022.07.013
   PubMed Web of Science ®Google Scholar
• Cox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017 Nov;23(11):812–818. doi: 10.1016/j.cmi.2017.07.010
   PubMed Web of Science ®Google Scholar
• Wattal C, Chakrabarti A, Oberoi JK, et al. Issues in antifungal stewardship: an opportunity that should not be lost. J Antimicrob Chemother. 2017 Apr 1;72(4):969–974. doi: 10.1093/jac/dkw506
   PubMed Web of Science ®Google Scholar
• Orefuwa E, Gangneux JP, Denning DW. The challenge of access to refined fungal diagnosis: an investment case for low- and middle-income countries. J Mycol Med. 2021 Jun;31(2):101140. doi: 10.1016/j.mycmed.2021.101140
   PubMed Web of Science ®Google Scholar
• Sathitakorn O, Chaononghin S, Katawethiwong P, et al. Strategies to limit invasive fungal infection in a coronavirus disease 2019 (COVID-19) intensive care unit: the role of infection prevention for renovation and construction in resource-limited settings. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e74. doi: 10.1017/ash.2022.35
   PubMedGoogle Scholar
• Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of medical mycology in cooperation with the Mycoses study group education and research Consortium. Lancet Infect Dis. 2019 Dec;19(12):e405–e421. doi: 10.1016/S1473-3099(19)30312-3
   PubMed Web of Science ®Google Scholar
• Maki G, Zervos M. Health care-acquired infections in low- and middle-income countries and the role of infection prevention and control. Infect Dis Clin North Am. 2021 Sep;35(3):827–839. doi: 10.1016/j.idc.2021.04.014
   PubMed Web of Science ®Google Scholar
• Schroeder LF, Guarner J, Amukele TK. Essential diagnostics for the use of world health organization essential medicines. Clin Chem. 2018 Aug;64(8):1148–1157. doi: 10.1373/clinchem.2017.275339
   PubMed Web of Science ®Google Scholar
• Executive summary: the selection and use of essential medicines 2021: report of the 23rd WHO Expert Committee on the selection and use of essential medicines. 2021 [cited 2023 Jun 1]. Available from: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.01
   Google Scholar
• WHO fungal priority pathogens list to guide research, development and public health action. 2022 [cited 2023 Aug 7]. Available from: https://www.who.int/publications/i/item/9789240060241
   Google Scholar
• Fisher MC, Denning DW. The WHO fungal priority pathogens list as a game-changer. Nature Rev Microbiol. 2023;21(4):211–212. doi: 10.1038/s41579-023-00861-x
   PubMed Web of Science ®Google Scholar